← Eichor
Condition: End Stage Kidney Disease Esrd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: End Stage Kidney Disease Esrd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING
Phase N/A · 1 location(s) · Sindh Institute of Urology and Transplantation · NCT07570771Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease.
Phase N/A · 1 location(s) · Odense University Hospital · NCT05266092EndoForce Post Approval Study
Phase N/A · 2 location(s) · Phraxis, Inc. · NCT07146854Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
NA · 2 location(s) · University of Avignon · NCT07269379Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins
Phase N/A · 1 location(s) · Xinhua Hospital, Shanghai Jiao Tong University School of Med · NCT07016841The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Populati
Phase N/A · 1 location(s) · Ain Shams University · NCT06755372REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Phase 3 · 8 location(s) · VA Office of Research and Development · NCT05931276Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Phase 1/Phase 2 · 2 location(s) · United Therapeutics · NCT06878560Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Phase N/A · 1 location(s) · Mahidol University · NCT06700876Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
NA · 1 location(s) · Oman Ministry of Health · NCT07491042Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure
NA · 1 location(s) · Guillermo Galeote; MD, PhD · NCT05353946Evolution of Bone Histomorphometry and Vascular Calcification Before and After Renal Transplantation
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT01886950Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study
NA · 2 location(s) · Xeltis · NCT06329310Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06903559RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)
NA · 1 location(s) · Azienda Ospedaliero-Universitaria Consorziale Policlinico di · NCT04360694Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Phase 2 · 5 location(s) · Hansa Biopharma AB · NCT05753930A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731The Agenda-Setting for Kidney Disease Open Pilot Trial
NA · 2 location(s) · Dartmouth-Hitchcock Medical Center · NCT07221604Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
Phase 3 · 4 location(s) · Dr. F. Köhler Chemie GmbH · NCT03627013A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Phase 1/Phase 2 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07607197Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Ma
Phase 4 · 21 location(s) · Chengdu Qingshan Likang Pharmaceutical Co., Ltd · NCT06597201Comparison of Hemodialysis Techniques in the Removal of Uremic Toxins in Chronic Renal Failure
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06794216Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Phase 2 · 18 location(s) · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · NCT04580420A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients
NA · 21 location(s) · W.L.Gore & Associates · NCT04671771CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Phase 3 · 2 location(s) · Vanderbilt University Medical Center · NCT05422534Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Phase N/A · 1 location(s) · University of Leicester · NCT03586518Kinesiophobia, Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients
Phase N/A · 1 location(s) · Kirsehir Ahi Evran Universitesi · NCT06696274
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.